TY - JOUR
T1 - Dynamics of human hematopoietic stem and progenitor cell differentiation to the erythroid lineage
AU - Schippel, Natascha
AU - Sharma, Shalini
N1 - Funding Information: This work was supported by funds to SS from the National Institutes of General Medical Sciences ( GM127464 ) and National Cancer Institute ( P30CA023074 ) of the National Institutes of Health, the Valley Research Partnership Program ( VRP P1-4009 ), and the Arizona Biomedical Research Center ( ABRC: 2022-010-30 ) and funds to NS and SS from the VRP77 grant. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. All figures were created using BioRender.com. Publisher Copyright: © 2023 ISEH – Society for Hematology and Stem Cells
PY - 2023/7
Y1 - 2023/7
N2 - Erythropoiesis, the development of erythrocytes from hematopoietic stem cells, occurs through four phases: erythroid progenitor (EP) development, early erythropoiesis, terminal erythroid differentiation (TED), and maturation. According to the classical model that is based on immunophenotypic profiles of cell populations, each of these phases comprises multiple differentiation states that arise in a hierarchical manner. After segregation of lymphoid potential, erythroid priming begins during progenitor development and progresses through progenitor cell types that have multilineage potential. Complete separation of the erythroid lineage is achieved during early erythropoiesis with the formation of unipotent EPs: burst-forming unit-erythroid and colony-forming unit-erythroid. These erythroid-committed progenitors undergo TED and maturation, which involves expulsion of the nucleus and remodeling to form functional biconcave, hemoglobin-filled erythrocytes. In the last decade or so, many studies employing advanced techniques such as single-cell RNA-sequencing (scRNA-seq) as well as the conventional methods, including colony-forming cell assays and immunophenotyping, have revealed heterogeneity within the stem, progenitor, and erythroblast stages, and uncovered alternate paths for segregation of erythroid lineage potential. In this review, we provide an in-depth account of immunophenotypic profiles of all cell types within erythropoiesis, highlight studies that demonstrate heterogeneous erythroid stages, and describe deviations to the classical model of erythropoiesis. Overall, although scRNA-seq approaches have provided new insights, flow cytometry remains relevant and is the primary method for validation of novel immunophenotypes.
AB - Erythropoiesis, the development of erythrocytes from hematopoietic stem cells, occurs through four phases: erythroid progenitor (EP) development, early erythropoiesis, terminal erythroid differentiation (TED), and maturation. According to the classical model that is based on immunophenotypic profiles of cell populations, each of these phases comprises multiple differentiation states that arise in a hierarchical manner. After segregation of lymphoid potential, erythroid priming begins during progenitor development and progresses through progenitor cell types that have multilineage potential. Complete separation of the erythroid lineage is achieved during early erythropoiesis with the formation of unipotent EPs: burst-forming unit-erythroid and colony-forming unit-erythroid. These erythroid-committed progenitors undergo TED and maturation, which involves expulsion of the nucleus and remodeling to form functional biconcave, hemoglobin-filled erythrocytes. In the last decade or so, many studies employing advanced techniques such as single-cell RNA-sequencing (scRNA-seq) as well as the conventional methods, including colony-forming cell assays and immunophenotyping, have revealed heterogeneity within the stem, progenitor, and erythroblast stages, and uncovered alternate paths for segregation of erythroid lineage potential. In this review, we provide an in-depth account of immunophenotypic profiles of all cell types within erythropoiesis, highlight studies that demonstrate heterogeneous erythroid stages, and describe deviations to the classical model of erythropoiesis. Overall, although scRNA-seq approaches have provided new insights, flow cytometry remains relevant and is the primary method for validation of novel immunophenotypes.
UR - http://www.scopus.com/inward/record.url?scp=85160354059&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85160354059&partnerID=8YFLogxK
U2 - 10.1016/j.exphem.2023.05.001
DO - 10.1016/j.exphem.2023.05.001
M3 - Review article
C2 - 37172755
SN - 0301-472X
VL - 123
SP - 1
EP - 17
JO - Experimental Hematology
JF - Experimental Hematology
ER -